News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Regulatory Round-up - September 2022Regulatory Round-up - September 2022Potential to accelerate development in ATMP space demonstrated by ATTC Network partnerPotential to accelerate development in ATMP space demonstrated by ATTC Network partnerCell & Gene Therapy Catapult at Advanced Therapies Europe 2022: A Bird’s Eye BlogCell & Gene Therapy Catapult at Advanced Therapies Europe 2022: A Bird’s Eye BlogAchieve commercial success: the value of a sound manufacturing strategyAchieve commercial success: the value of a sound manufacturing strategyPress Release: Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform to enable cell therapy commercialisationPress Release: Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform to enable cell therapy commercialisationPress release: CGT Catapult begins Virtual Reality training to help ensure future workforce needsPress release: CGT Catapult begins Virtual Reality training to help ensure future workforce needsRegulatory Round-up - August 2022Regulatory Round-up - August 2022Learning the lessons of today to deliver the treatments of tomorrowLearning the lessons of today to deliver the treatments of tomorrowRegulatory Round-up - July 2022Regulatory Round-up - July 2022High Commission of Canada and ISED visit CGT Catapult Manufacturing Innovation CentreHigh Commission of Canada and ISED visit CGT Catapult Manufacturing Innovation CentreCGT Catapult Joins New Consortium to Advance Personalised Cell Therapy ManufacturingCGT Catapult Joins New Consortium to Advance Personalised Cell Therapy ManufacturingRegulatory Round-up - June 2022Regulatory Round-up - June 2022